FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Faron Pharmaceuticals: Faron publishes final results of its EUR 40.1 million rights issue
Faron Pharmaceuticals: Inside Information: Faron publishes preliminary results of its successful rights issue
Director Dealing
Faron appoints new CTO to strengthen late-stage development activities
Director Dealing
HOLDING(S) IN COMPANY
Director Dealing
Director Dealing
Director Dealing
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
Faron Pharmaceuticals: Inside Information: Faron publishes the terms and conditions of a fully covered rights offering of approximately EUR 40 million and updates cash runway
Faron Pharmaceuticals: Correction: Faron Pharmaceuticals Ltd’s Annual Report 2025 published
Faron Pharmaceuticals: Faron Pharmaceuticals Ltd’s Annual Report 2025 published
Faron Pharmaceuticals: Faron’s Financial Statements Release 1 January to 31 December 2025
Brief: Faron Pharmaceuticals Plans Rights Offering Of EUR 40 Mln
NOTICE TO THE EXTRAORDINARY GENERAL MEETING
Registration of New Shares
Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First and Second Tranche Bonds